NO965523L - Filtrering - Google Patents

Filtrering

Info

Publication number
NO965523L
NO965523L NO965523A NO965523A NO965523L NO 965523 L NO965523 L NO 965523L NO 965523 A NO965523 A NO 965523A NO 965523 A NO965523 A NO 965523A NO 965523 L NO965523 L NO 965523L
Authority
NO
Norway
Prior art keywords
filtering
sodium
virus
potassium
filtration
Prior art date
Application number
NO965523A
Other languages
English (en)
Other versions
NO965523D0 (no
NO320952B1 (no
Inventor
Stefan Winge
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26662085&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO965523(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE9402254A external-priority patent/SE502820C2/sv
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of NO965523L publication Critical patent/NO965523L/no
Publication of NO965523D0 publication Critical patent/NO965523D0/no
Publication of NO320952B1 publication Critical patent/NO320952B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717—Plasma globulins, lactoglobulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Water Supply & Treatment (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Glass Compositions (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
NO19965523A 1994-06-23 1996-12-20 Fremgangsmate for virusfiltrering av en losning inneholdende minst ett makromolekyl NO320952B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9402254A SE502820C2 (sv) 1994-06-23 1994-06-23 Filtrering
SE9500724A SE9500724D0 (sv) 1994-06-23 1995-02-24 Filtrering
PCT/SE1995/000777 WO1996000237A1 (en) 1994-06-23 1995-06-22 Filtration

Publications (3)

Publication Number Publication Date
NO965523L true NO965523L (no) 1996-12-20
NO965523D0 NO965523D0 (no) 1996-12-20
NO320952B1 NO320952B1 (no) 2006-02-20

Family

ID=26662085

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19965523A NO320952B1 (no) 1994-06-23 1996-12-20 Fremgangsmate for virusfiltrering av en losning inneholdende minst ett makromolekyl

Country Status (16)

Country Link
US (4) US6486306B1 (no)
EP (1) EP0796269B1 (no)
JP (1) JP3676370B2 (no)
AT (1) ATE212354T1 (no)
CA (1) CA2192683C (no)
DE (2) DE69525176T2 (no)
DK (1) DK0796269T3 (no)
ES (1) ES2105992T3 (no)
FI (1) FI965145A7 (no)
GR (1) GR970300038T1 (no)
MX (1) MX9606639A (no)
NO (1) NO320952B1 (no)
NZ (1) NZ288789A (no)
PT (1) PT796269E (no)
SE (1) SE9500724D0 (no)
WO (1) WO1996000237A1 (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500724D0 (sv) * 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
SE9500778D0 (sv) * 1995-03-03 1995-03-03 Pharmacia Ab Process for producing a protein
SE9603068D0 (sv) * 1996-08-23 1996-08-23 Pharmacia & Upjohn Ab Process for purifying a protein
SE9603303D0 (sv) 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a protein
EP0860444A1 (en) * 1997-02-24 1998-08-26 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis (CLB) Method for removing viruses from a protein solution
US7534304B2 (en) 1997-04-29 2009-05-19 Whirlpool Corporation Non-aqueous washing machine and methods
US6045588A (en) 1997-04-29 2000-04-04 Whirlpool Corporation Non-aqueous washing apparatus and method
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
FR2772381B1 (fr) † 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
US6861001B2 (en) * 1999-12-02 2005-03-01 The General Hospital Corporation Methods for removal, purification, and concentration of viruses, and methods of therapy based thereupon
US7513132B2 (en) 2003-10-31 2009-04-07 Whirlpool Corporation Non-aqueous washing machine with modular construction
CA2487072A1 (en) 2002-05-23 2003-12-04 Ortho-Clinical Diagnostics, Inc. Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration
CA2489123C (en) * 2002-06-14 2011-03-15 Centocor, Inc. Use of a clathrate modifier to promote passage of proteins during nanofiltration
JP2004099506A (ja) * 2002-09-09 2004-04-02 Mitsubishi Rayon Co Ltd アミノ酸アミドの製造方法
US8258264B2 (en) * 2003-04-09 2012-09-04 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Process for producing albumin preparation
CN100398642C (zh) * 2003-06-20 2008-07-02 迈克必斯生物系统公司 病毒生产的改进
ATE478137T1 (de) * 2003-06-20 2010-09-15 Microbix Biosystems Inc Verbesserungen bei der virusproduktion
FR2861395B1 (fr) 2003-10-23 2006-02-17 Lab Francais Du Fractionnement Facteur viii viralement securise a faible teneur en multimeres superieurs
US7513004B2 (en) 2003-10-31 2009-04-07 Whirlpool Corporation Method for fluid recovery in a semi-aqueous wash process
US7300468B2 (en) 2003-10-31 2007-11-27 Whirlpool Patents Company Multifunctioning method utilizing a two phase non-aqueous extraction process
US7739891B2 (en) 2003-10-31 2010-06-22 Whirlpool Corporation Fabric laundering apparatus adapted for using a select rinse fluid
US7695524B2 (en) 2003-10-31 2010-04-13 Whirlpool Corporation Non-aqueous washing machine and methods
CN106916802B (zh) 2003-12-01 2022-03-25 诺和诺德医疗保健公司 液体因子vii组合物的病毒过滤
ES2329607T3 (es) 2004-02-23 2009-11-27 Crucell Holland B.V. Metodos de purificacion de virus.
FR2866890B1 (fr) 2004-02-27 2008-04-04 Lab Francais Du Fractionnement Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
US7837741B2 (en) 2004-04-29 2010-11-23 Whirlpool Corporation Dry cleaning method
WO2005113119A1 (en) * 2004-05-21 2005-12-01 Wisconsin Alumni Research Foundation Membrane cascade-based separation
AU2005229674B2 (en) 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
US8574595B2 (en) 2005-04-11 2013-11-05 Crucell Holland B.V. Virus purification using ultrafiltration
US7966684B2 (en) 2005-05-23 2011-06-28 Whirlpool Corporation Methods and apparatus to accelerate the drying of aqueous working fluids
ES2775974T3 (es) * 2006-06-26 2020-07-28 Omrix Biopharmaceuticals Inc Eliminación de virus por nanofiltración
DE602008006410D1 (de) * 2007-06-15 2011-06-01 Amgen Inc Verfahren zur behandlung von zellkulturmedien für die verwendung in einem bioreaktor
KR100870423B1 (ko) * 2007-06-27 2008-11-26 주식회사 하이닉스반도체 반도체메모리소자
US7989593B1 (en) 2010-05-27 2011-08-02 Bing Lou Wong Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
US7932356B1 (en) 2010-06-23 2011-04-26 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
US8048856B1 (en) 2010-06-23 2011-11-01 Billion King, Ltd. Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
US8084581B1 (en) 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
EP2725033B1 (en) * 2011-06-24 2017-08-09 Asahi Kasei Medical Co., Ltd. Method for producing protein preparation
US20130052232A1 (en) 2011-08-31 2013-02-28 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking
US9294158B2 (en) 2012-08-07 2016-03-22 Broadcom Corporation Broadcast audio service
AU2014305646C1 (en) 2013-08-08 2019-01-17 Csl Limited Contaminant removal method
US10053296B2 (en) 2016-09-19 2018-08-21 Asgco Manufacturing, Inc. Return idler trainer
WO2025235738A1 (en) * 2024-05-08 2025-11-13 Interius Biotherapeutics, Inc. Methods of detecting residual dna in viral preparations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870801A (en) 1968-08-09 1975-03-11 Lever Brothers Ltd Fluid aqueous protein compositions and food products prepared therefrom
US3919044A (en) 1973-03-28 1975-11-11 Armour Pharma Processes for concentrating and purifying viruses and viral antigens
US3874999A (en) 1973-10-31 1975-04-01 American Cyanamid Co Process for the purification of virus vaccine
CA1099576A (en) 1978-03-23 1981-04-21 Chester D. Myers Improved process for isolation of proteins
US4473494A (en) 1983-05-04 1984-09-25 The United States Of America As Represented By The Secretary Of The Army Preparation of stroma-free, non-heme protein-free hemoglobin
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
JPH0720986B2 (ja) 1985-10-07 1995-03-08 日本ケミカルリサ−チ株式会社 生理活性物質の製造法
AU605901B2 (en) 1987-09-11 1991-01-24 Ares Trading S.A. Purification process
RU1781355C (ru) * 1990-04-23 1992-12-15 В.П.Широбоков, Л.Я.Палиенко, А.И.Евтушенко, Л.А Коптюх, Ю.В.Загороднюк и К.Д Стеценко Фильтрующий материал
US5017292A (en) 1990-05-10 1991-05-21 Millipore Corporation Membrane, process and system for isolating virus from solution
US5221483A (en) * 1990-06-29 1993-06-22 Coulter Corporation Process and apparatus for removal of DNA, viruses and endotoxins
US5076933A (en) 1990-06-29 1991-12-31 Coulter Corporation Process and apparatus for removal of dna and viruses
SE9301582D0 (sv) 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins
SE9500724D0 (sv) * 1994-06-23 1995-02-24 Pharmacia Ab Filtrering

Also Published As

Publication number Publication date
DK0796269T3 (da) 2002-05-06
PT796269E (pt) 2002-06-28
EP0796269A1 (en) 1997-09-24
EP0796269B1 (en) 2002-01-23
DE796269T1 (de) 1998-01-02
AU2813295A (en) 1996-01-19
FI965145L (fi) 1996-12-20
MX9606639A (es) 1997-03-29
CA2192683A1 (en) 1996-01-04
JPH10502074A (ja) 1998-02-24
GR970300038T1 (en) 1997-11-28
ES2105992T1 (es) 1997-11-01
ES2105992T3 (es) 2002-09-16
JP3676370B2 (ja) 2005-07-27
NZ288789A (en) 1997-12-19
SE9500724D0 (sv) 1995-02-24
ATE212354T1 (de) 2002-02-15
NO965523D0 (no) 1996-12-20
US6486306B1 (en) 2002-11-26
AU682274B2 (en) 1997-09-25
NO320952B1 (no) 2006-02-20
US6399357B1 (en) 2002-06-04
DE69525176D1 (de) 2002-03-14
US20050203285A1 (en) 2005-09-15
FI965145A0 (fi) 1996-12-20
FI965145A7 (fi) 1996-12-20
US20030191292A1 (en) 2003-10-09
ES2105992T2 (es) 1997-11-01
DE69525176T2 (de) 2002-06-27
CA2192683C (en) 2005-07-05
WO1996000237A1 (en) 1996-01-04

Similar Documents

Publication Publication Date Title
SE9500724D0 (sv) Filtrering
FI935304L (fi) Ionisten, samepistettä modifioivien aineiden käyttö hiukkasten kasautumisen estämiseen steriloinnin aikana
FR2585044B1 (fr) Additif granulaire de detergent, procedes pour le preparer et composition detergente le contenant
IT8423211A0 (it) Procedimento per ridurre completamente o in parte la permeabilita' di un tessuto industriale.
DE69124595D1 (de) Verfahren zur Durchflusszytometrie-Unterscheidung der Erythroblasten von anderen Zellen
DE3680271D1 (de) Thrombolytische zusammensetzung und verfahren zu deren herstellung.
YU47449B (sh) Rastvor celuloze u vodi i n-metil-morfolin-n-oksidu
SE8300320L (sv) Anvendning av en saltlosning av monoklonala antikroppar med relativt hog salthalt vid blodgruppsbestemning
NO167466C (no) Fremgangsmaate for redusering av saltinnholdet i raaolje
FI843005A7 (fi) 1,6-naftyridioni-johdannaiset, niiden valmistusmenetelmä ja käyttö suonisairauksien estossa
IT1178739B (it) Perfezionamenti relativi al controllo di elementi astiformi, in particolare sigarette e/o filtri per sigarette
MY103079A (en) New ophtalmological composition of matter
GB2090308B (en) Stabilized solutions of modified cellulose in brine and their use as completion and workover fluids
DE58903876D1 (de) Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz.
BE876204A (fr) Composition en vue de reduire le taux de phenylalanine dans le sang, et son procede d'utilisation
AU589970B2 (en) Animal litter and process for the production thereof
GR860329B (en) Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof
ATE25107T1 (de) Verfahren zur herstellung von seifenpulver.
DE3771260D1 (de) Kalziumkarbonatsuspension enthaltende pharmazeutische zusammensetzung.
PH21141A (en) New derivatives of 2-(3-pyridyl)-2-phenyl-aminoacetic acid and their use as antifungals in the field of agriculture
KR870002255A (ko) 인삼 재생 작물의 제조방법
BG31214A3 (en) Method for obtaining of human albumine
HU209389B (en) Method for producing tetrasodium salt of 1,4,10,13-tetraoxa-7,16-diaza-cyclooctadecane-n,n'-dimalonic acid with sodium bromide content and one for producing medical preparatives containing said compound
ATE31623T1 (de) Injizierbare zusammensetzungen von bbm-928a.
GB1208491A (en) Improvements in tobacco filters

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees